Pharma Pulse: Navigating the Biosecure Act, Post-Viral Sleep Phenotypes, and Rising Insurance Costs

In today’s Pharma Pulse, the Senate advances legislation to block "biotechnology companies of concern," clinical research ties COVID-19 to REM-dominant sleep apnea, and a new analysis reveals an affordability breaking point for employer-sponsored health insurance.